As of 2025-09-17, the EV/EBITDA ratio of KemPharm Inc (KMPH) is -6.44. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KMPH's latest enterprise value is 153.95 mil USD. KMPH's TTM EBITDA according to its financial statements is -23.90 mil USD. Dividing these 2 quantities gives us the above KMPH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.8x - 10.8x | 7.5x |
| Forward P/E multiples | 8.8x - 17.3x | 12.3x |
| Fair Price | (4.73) - (6.13) | (5.51) |
| Upside | -181.5% - -205.5% | -194.8% |
| Date | EV/EBITDA |